Prevalence, patterns and associated risk factors for dyslipidaemia among individuals attending the diabetes clinic at a tertiary hospital in Central Malawi

被引:0
作者
Filisa-Kaphamtengo, Florence [1 ,2 ]
Ngoma, Jonathan [1 ]
Mukhula, Victoria [3 ,4 ]
Matemvu, Zaithwa [1 ]
Kapute, Deborah [5 ]
Banda, Peter [6 ]
Phiri, Tamara [7 ]
Mipando, Mwapatsa [4 ,8 ]
Hosseinipour, Mina C. [9 ]
Katundu, Kondwani G. H. [2 ,3 ,4 ]
机构
[1] Kamuzu Cent Hosp, Lilongwe, Malawi
[2] Kamuzu Univ Hlth Sci, Sch Global & Publ Hlth, Blantyre, Malawi
[3] Malawi Liverpool Wellcome Clin Res Program, Blantyre, Malawi
[4] Kamuzu Univ Hlth Sci, Blantyre Blantyre Res Facil, Blantyre, Malawi
[5] Blantyre Adventist Hosp, Blantyre, Malawi
[6] Kamuzu Univ Hlth Sci, Dept Med, Blantyre, Malawi
[7] Queen Elizabeth Cent Hosp, Dept Med, Blantyre, Malawi
[8] Kamuzu Univ Hlth Sci, Dept Biomed Sci, Blantyre, Malawi
[9] Univ North Carolina Project Lilongwe, Lilongwe, Malawi
关键词
Dyslipidaemia; Atherosclerotic cardiovascular disease; Diabetes mellitus; Kamuzu central hospital; Malawi; OBESITY; PREVENTION; MANAGEMENT; NUTRITION; AFRICA; CARE;
D O I
10.1186/s12872-023-03589-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDyslipidaemia among individuals with diabetes is a significant modifiable risk factor for atherosclerotic cardiovascular diseases (ASCVDs). ASCVDs are a major cause of mortality and morbidity globally, especially in people with diabetes. In Malawi, limited data exist on the prevalence and biochemical characteristics of diabetic dyslipidaemia. This study investigated the prevalence and biochemical characteristics of dyslipidaemia in individuals attending the diabetes clinic at Kamuzu Central Hospital, the largest tertiary referral hospital in Central Malawi.MethodsUsing a cross-sectional design, sociodemographic, medical and anthropometric data were collected from 391 adult participants who were enrolled in the study. Blood samples were analysed for glycosylated haemoglobin (HBA1c) and fasting lipid profiles. The prevalence of dyslipidaemia was calculated, and the biochemical characteristics of the dyslipidaemia were defined. The associations between dyslipidaemia and risk factors such as sociodemographic characteristics, obesity, and HBA1c levels were evaluated using logistic regression analysis.ResultsPrevalence of dyslipidaemia was observed in 71% of the participants, and elevated low-density lipoprotein cholesterol was the most frequent lipid abnormality among the study participants. None of the participants were receiving any lipid-lowering therapy. On bivariate analysis, dyslipidemia was positively associated with female sex [OR 1.65 (95% CI 1.05- 2.58); p = 0.09], age >= 30 years [OR 3.60 (95% CI 1.17-7.68); p = 0.001] and overweight and obesity [OR 2.11 (95% CI 1.33-3.34); p = 0.002]. On multivariate analysis, being overweight or obese was an independent predictor of dyslipidaemia [AOR 1.8;(95% CI 1.15- 3.37); p = 0.04].ConclusionDyslipidaemia was highly prevalent among individuals with diabetes in this study, and elevated low-density lipoprotein cholesterol was the most frequent lipid abnormality. Overweight and obesity were also highly prevalent and positively predicted dyslipidaemia. This study highlights the importance of appropriately addressing dyslipidaemia, overweight and obesity among individuals with diabetes in Malawi and other similar settings in Africa as one of the significant ways of reducing the risk of ASCVDs among this population.
引用
收藏
页数:8
相关论文
共 45 条
  • [1] Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
  • [2] Diabetes and lipid metabolism
    Athyros, Vasilios G.
    Doumas, Michael
    Imprialos, Konstantinos P.
    Stavropoulos, Konstantinos
    Georgianou, Eleni
    Katsimardou, Alexandra
    Karagiannis, Asterios
    [J]. HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 17 (01): : 61 - 67
  • [3] Blom DJ, 2013, South African Journal of Diabetes and Vascular Disease, V10, P48
  • [4] Why have total cholesterol levels declined in most developed countries?
    Capewell, Simon
    Ford, Earl S.
    [J]. BMC PUBLIC HEALTH, 2011, 11
  • [5] Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S103 - S123
  • [6] Daya R, 2017, JEMDSA, V22, P31, DOI 10.1080/16089677.2017.1360064
  • [7] Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case-Control Study Using Quebec's Public Health Insurance Database
    Durand, Madeleine
    Sheehy, Odile
    Baril, Jean-Guy
    Lelorier, Jacques
    Tremblay, Cecile L.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (03) : 245 - 253
  • [8] Federation ID., 2021, IDF Diabetes Atlas Brussels
  • [9] Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
    Feinstein, Matthew J.
    Hsue, Priscilla Y.
    Benjamin, Laura A.
    Bloomfield, Gerald S.
    Currier, Judith S.
    Freiberg, Matthew S.
    Grinspoon, Steven K.
    Levin, Jules
    Longenecker, Chris T.
    Post, Wendy S.
    [J]. CIRCULATION, 2019, 140 (02) : E98 - E124
  • [10] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
    Ference, Brian A.
    Ginsberg, Henry N.
    Graham, Ian
    Ray, Kausik K.
    Packard, Chris J.
    Bruckert, Eric
    Hegele, Robert A.
    Krauss, Ronald M.
    Raal, Frederick J.
    Schunkert, Heribert
    Watts, Gerald F.
    Boren, Jan
    Fazio, Sergio
    Horton, Jay D.
    Masana, Luis
    Nicholls, Stephen J.
    Nordestgaard, Borge G.
    van de Sluis, Bart
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Landmesser, Ulf
    Laufs, Ulrich
    Wiklund, Olov
    Stock, Jane K.
    Chapman, M. John
    Catapano, Alberico L.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (32) : 2459 - 2472